Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
240.00
-4.35 (-1.78%)
Jul 18, 2025, 4:00 PM EDT

Sartorius Stedim Biotech Company Description

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.

It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products.

In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions.

It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories.

The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech logo
CountryFrance
Founded1978
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees9,901
CEORene Faber

Contact Details

Address:
Zone Industrielle Les Paluds
Aubagne, 13781
France
Phone33 4 42 84 56 00
Websitesartorius.com

Stock Details

Ticker SymbolSDMHF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberFR0013154002
SIC Code3826

Key Executives

NamePosition
Dr. Rene FaberChief Executive Officer and DIrector
Petra MullerHead of Investor Relations
Petra KirchhoffHead of Corporate Communications and IR